Long-term follow-up of cancer risk in patients treated with short-term cyclosporine

Acta Dermato-Venereologica

Volumn 88, Issue 2, 2008, Pages 117-120

  Väkevä, Liisa ^a   Reitamo, Sakari ^a   Pukkala, Eero ^b   Sarna, Seppo ^c   Ranki, Annamari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cancer risk; Cohort study; Cyclosporine; Follow up study; Inflammatory skin diseases

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; ATOPIC DERMATITIS; BRAIN TUMOR; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CARCINOID; COHORT ANALYSIS; DRUG INDUCED CANCER; DRUG RESPONSE; FEMALE; FOLLOW UP; HAND ECZEMA; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MOUTH CANCER; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; PSORIASIS; PUSTULOSIS PALMOPLANTARIS; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; TESTIS CANCER; TREATMENT DURATION; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA; MALE; MIDDLE AGED; RISK FACTORS; SKIN DISEASES; SKIN NEOPLASMS;

EID: 41949115520     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0360     Document Type: Article

References (28)

1. Bunjes D, Hardt C, Rollinghoff M, Wagner H. Cyclosporine A mediates immunosuppression of primary cytotoxic T-cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol 1981; 11: 657-661.
2. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ tranplantation. N Engl J Med 2003; 348: 1681-1691.
3. Glover M, Deeks J, Raftery M, Cunningham J, Leigh I. Immunosuppression and risk of nonmelanoma skin cancer in renal transplant recipients. Lancet 1997; 349: 398-399.
4. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regiments. J Am Acad Dermatol 1999; 40: 177-186.
5. Mueller W, Herrmann B. Cyclosporine A for psoriasis. N Engl J Med 1979; 301: 555.
6. Marcil I, Stern RS. Squamous cell cancer of the skin in patients given PUVA and cyclosporin: nested cohort crossover study. Lancet 2001; 358: 1042-1045.
7. Paul C, Ho V, Mc Geown C, Christophers E, Schmidtmann B, Guillaume JC, et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 2003; 120: 211-216.
8. Reitamo S, Erkko P. Remitz A, Lauerma AI, Montonen O, Harjula K. Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study. Arch Dermatol 1993; 129: 1273-1279.
9. Ho VC, Griffiths CE, Albrecht G, Vanaclocha F, Leon-Dorantes G, Atakan N, et al. Intermittent short courses of cyclosporine (Neoral (R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group. Br J Dermatol 1999; 141: 283-291.
10. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol 1989; 144: 13-14.
11. Granlund H, Erkko P, Sinisalo M, Reitamo S. Cyclosporine A in atopic dermatitis: time to relapse and intermittent therapy. Br J Dermatol 1995; 132: 106-112.
12. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17, 21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol 1996; 76: 371-376.
13. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population based cancer registry. Experience in Finland. Acta Oncologica 1994; 33: 365-369.
14. Pukkala E: Use of record linkage in small area studies. In: Elliot P, Cuzick J, English D, Stern R, editors. Geographical and environmental epidemiology. Oxford: Oxford University Press, 1992.
15. Machin D, Campbell MJ, editors. Statistical tables for the design of clinical trials. Oxford: Blackwell Scientific Publications, 1987.
16. Berg D, Otley C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis and management. J Am Acad Dermatol 2002; 47: 1-17.
17. Kyllönen L, Pukkala E, Eklund B. Cancer incidence in a kidney-transplanted population. Transplant Int 1994; 7: 350-352.
18. O'Donovan P, Perrett C, Zhang X, Montaner B, Xu YZ, Harwood CA, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871-1874.
19. Hannuksela-Svahn A, Pukkala E, Poikolainen K, Karvonen J. Psoriasis, its treatment and cancer in a cohort of Finnish patients. J Invest Dermatol 2000; 114: 587-590.
20. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85: 307-311.
21. Lindelöf B, Sigurgeirsson B, Tegner E, Larkö O, Johannesson A, Berne B, et al. PUVA and cancer: a large scale epidemiological study. Lancet 1991; 338: 91-93.
22. Stern RS, Laird R. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994; 73: 2759-2764.
23. Arellano F, Krupp P. Malignancies in rheumatoid arthritis patients treated with cyclosporine A. Br J Rheumatol 1993; 32: 72-75.
24. van den Borne BE, Landewe RB, Houkes I, Schild F, van der Heyden PC, Hazes JM, et al. No increased risk of malignancies and mortality in cyclosporine A-treated patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 1930-1937.
25. Berth-Jones J, Graham-Brown RA, Marks R, Camp RD, English JS, Freeman K, et al. Long-term efficacy and safety of cyclosporine in severe adult atopic dermatitis. Br J Dermatol 1997; 136: 76-81.
26. Bavinck JN, de Boer A, Vermeer BJ, Artevelt MM, van der Woude FJ, Claas FH, et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129: 242-249.
27. Bavink Bouves JN, Hardie DR, Green A, Cutmore S, MacNaught A, O' Sullivan B, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61: 715-721.
28. Ramsay HM, Fryer AA, Reece S, Smith AG, Harden PN. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000; 36: 167-176.